𝔖 Bobbio Scriptorium
✦   LIBER   ✦

FC035 A comparison of two formulations of cyclosporin in severe psoriasis

✍ Scribed by J. Berth-Jones; T. Ruzicka

Book ID
118604319
Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
123 KB
Volume
9
Category
Article
ISSN
0926-9959

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A randomized, double-blind study compari
A randomized, double-blind study comparing the efficacy, safety and optimal dose of two formulations of cyclosporin, Neoral and Sandimmun, in patients with severe psoriasis
✍ Koo; FOR THE OLP302 STUDY GROUP πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 787 KB

This study compared the efficacy, safety and optimal dose of two formulations of cyclosporin, Sandimmun and Neoral, in patients with severe, chronic plaque-type psoriasis. Patients were randomized on a 1:1 basis to 24 weeks of treatment with Neoral (n = 152) or Sandimmun (n = 157). The starting dose

Change of treatment from cyclosporin to
Change of treatment from cyclosporin to mycophenolate mofetil in severe psoriasis
✍ S.C. Davison; R. Morris-Jones; A.V. Powles; L. Fry πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 192 KB

Eight patients whose severe psoriasis was treated with long-term cyclosporin (range 2-11 years; mean 7.6 years) were changed to mycophenolate mofetil (MMF), because of nephrotoxicity in seven and hypertension and lack of efficacy in one. In five patients psoriasis control significantly deteriorated